Familial inflammatory dilated cardiomyopathy

European Journal of Heart Failure

Volumn 8, Issue 8, 2006, Pages 816-825

  Portig, Irene ^a   Wilke, Andreas ^a   Freyland, Matthias ^a   Wolf, Markus Joachim ^a   Richter, Anette ^a   Ruppert, Volker ^a   Pankuweit, Sabine ^a   Maisch, Bernhard ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Dilated cardiomyopathy; Familial dilated cardiomyopathy; Inflammatory DCM

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNITY; AUTOSOMAL RECESSIVE DISORDER; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; GENETICS; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADULT; AGED; CARDIOMYOPATHY, DILATED; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PEDIGREE;

EID: 33751183060     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2006.02.010     Document Type: Article

References (56)

1. Towbin J.A., Hejtmancik J.F., Brink P., et al. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 87 (1993) 1854-1865
2. Goldfarb L.G., Park K.-Y., Cervenáková L., et al. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet 19 (1998) 402-403
3. Bione S., Maestrini E., Rivella S., et al. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet 8 (1994) 323-327
4. Franz W.M., Muller M., Muller O.J., et al. Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy. Lancet 355 (2000) 1781-1785
5. Li D., Tapscoft T., Gonzalez O., et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 100 (1999) 461-464
6. Tsubata S., Bowles K.R., Vatta M., et al. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 106 (2000) 655-662
7. Barresi R., Di Blasi C., Negri T., et al. Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by δ-sarcoglycan mutations. J Med Genet 37 (2000) 102-107
8. Olson T.M., Michels V.V., Thibodeau S.N., Tai Y.S., and Keating M.T. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280 (1998) 750-752
9. Towbin J.A., and Bowles N.E. Genetic abnormalities responsible for dilated cardiomyopathy. Curr Cardiol Rep 2 (2000) 475-480
10. Murphy R.T., Mogensen J., Shaw A., Kubo T., Hughes S., and McKenna W.J. Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy. Lancet 363 (2004) 371-372
11. Olson T.M., Kishimoto N.Y., Whitby F.G., and Michels V.V. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol 33 (2001) 723-732
12. Kamisago M., Sharma S.D., DePalma S.R., et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 343 (2000) 1688-1696
13. Fatkin D., MacRae C., Sasaki T., et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 341 (1999) 1715-1724
14. Hutchison C.J., Alvarez-Reyes M., and Vaughan O.A. Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes?. J Cell Sci 114 (2001) 9-19
15. Sebillon P., Bouchier C., Bidot L.D., et al. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. J Med Genet 40 (2003) 560-567
16. Schönberger J, Zimmer M, Ertl G. Genetics in dilated cardiomyopathy. DÄ 2004;101:1099-1105 [available via www.aerzteblatt.de].
17. Schmitt J.P., Kamisago M., Asahi M., et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299 (2003) 1410-1413
18. Towbin J.A., and Bowles N.E. The failing heart. Nature 415 (2002) 227-233
19. Schonberger J., Levy H., Grunig E., et al. Dilated cardiomyopathy and sensorineural hearing loss: a heritable syndrome that maps to 6q23-24. Circulation 101 (2000) 1812-1818
20. Mestroni L., Rocco C., Gregori D., et al. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Coll Cardiol 34 (1999) 181-190
21. Aretz H.T. Myocarditis: the Dallas criteria. Hum Pathol 18 (1987) 619-624
22. Maisch B., Portig I., Ristic A., Hufnagel G., and Pankuweit S. Definition of inflammatory cardiomyopathy (myocarditis): on the way to consensus. A status report. Herz 25 (2000) 200-209. http://www.springerlink.com [available via www.springerlink.com]
23. Maisch B., Seferovic P.M., Ristic A.D., et al. Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary. Eur Heart J 25 (2004) 587-610
24. Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93 (1996) 841-842
25. Henry W.L., Gardin J.M., and Ware J.H. Echocardiographic measurements in normal subjects from infancy to old age. Circulation 62 (1980) 1054-1061
26. Mestroni L., Maisch B., McKenna W.J., et al. Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J 20 (1999) 10-93
27. Mues B., Brisse B., Zwadlo G., Themann H., Bender P., and Sorg C. Phenotyping of macrophages with monoclonal antibodies in endomyocardial biopsies as a new approach to diagnosis of myocarditis. Eur Heart J 11 (1990) 619-627
28. Pankuweit S., Portig I., Eckhardt H., Crombach M., Hufnagel G., and Maisch B. Prevalence of viral genome in endomyocardial biopsies from patients with inflammatory heart muscle disease. Herz 25 (2000) 221-226. http://www.springerlink.com [available via www.springerlink.com]
29. Ruppert V., Nolte D., Aschenbrenner T., Pankuweit S., Funck R., and Maisch B. Novel point mutations in the mitochondrial DNA detected in patients with dilated cardiomyopathy by screening the whole mitochondrial genome. Biochem Biophys Res Commun 318 (2004) 535-543
30. Mahon N.G., Murphy R.T., MacRae C.A., Caforio A.L., Elliott P.M., and McKenna W.J. Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease. Ann Intern Med 143 (2005) 108-115
31. Kass S., MacRae C., Graber H.L., et al. A genetic defect that causes conduction system disease and dilated cardiomyopathy maps to 1p1-1q21. Nat Genet 7 (1994) 546-551
32. Jung M., Poepping I., Perrot A., et al. Investigation of a family with autosomal dominant dilated cardiomyopathy defines a novel locus on chromosome 2q14-2q22. Am J Hum Genet 65 (1999) 1068-1077
33. Olson T.M., and Keating M.T. Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest 97 (1996) 528-532
34. Messina D.N., Speer M.C., Pericak-Vance A., and McNally E.M. Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am J Hum Genet 61 (1997) 909-917
35. Oropeza E.S., and Cadena C.N. New phenotype of familial dilated cardiomyopathy and conduction disorders. Am Heart J 145 (2003) 317-323
36. Brodsky G.L., Muntoni F., Miocic S., Sinagra G., Sewry C., and Mestroni L. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 101 (2000) 473-476
37. Bonne G., Di Barletta M.R., Varnous S., et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 21 (1999) 285-288
38. O'Connell J.B., Fowles R.E., Robinson J.A., Subramanian R., Henkin R.E., and Gunnar R.M. Clinical and pathologic findings of myocarditis in two families with dilated cardiomyopathy. Am Heart J 107 (1984) 127-135
39. Zatz M., Vainzof M., and Passos-Bueno M.R. Limb-girdle muscular dystrophy: one gene with different phenotypes, one phenotype with different genes. Curr Opin Neurol 13 (2000) 511-517
40. Matzinger P. The danger model: a renewed sense of self. Science 296 (2002) 301-305
41. Maisch B., Lamparter S., Ristic A., and Pankuweit S. Pregnancy and cardiomyopathies. Herz 28 (2003) 196-208
42. Rottem M., and Shoenfeld Y. Asthma as a paradigm for autoimmune disease. Int Arch Allergy Immunol 123 (2003) 210-214
43. Rathmell J.C., and Thompson C.B. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 109 (2002) S97-S107 [Suppl.]
44. Mackay I.R., and Rose N.R. Autoimmunity and lymphoma: tribulations of B cells. Nat Immunol 2 (2001) 793-795
45. Espinosa G., Font J., Munoz-Rodriguez F.J., Cervera R., and Ingelmo M. Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship?. Clin Rheumatol 21 (2002) 309-313
46. Olanoff L.S., and Fundenberg H.H. Familial autoimmunity: twenty years later. J Clin Lab Immunol 11 (1983) 105-111
47. Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 17 (1997) 399-403
48. Rieux-Laucat F., Le Deist F., Hivroz C., et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268 (1995) 1347-1349
49. Wu J., Wilson J., He J., Xiang L., Schur P.H., and Mountz J.D. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 98 (1996) 1107-1113
50. Coughlin S.S., Szklo M., Baughman K., and Pearson T.A. Idiopathic dilated cardiomyopathy and atopic disease: epidemiologic evidence for an association with asthma. Am Heart J 118 (1989) 768-774
51. Weinberger S.E. Recent advances in pulmonary medicine. N Engl J Med 328 (1993) 1389-1397
52. Alpaslan M., Onrat E., and Evcik D. Doppler echocardiographic evaluation of ventricular function in patients with rheumatoid arthritis. Clin Rheumatol 22 (2003) 84-87
53. Redondo M.J., and Eisenbarth G.S. Genetic control of autoimmunity in Type I diabetes and associated disorders. Diabetologia 45 (2002) 605-622
54. Marrack P., Kappler J., and Kotzin B.L. Autoimmune disease: why and where it occurs. Nat Med 7 (2001) 899-905
55. Tsao B.P. An update on genetic studies of systemic lupus erythematosus. Curr Rheumatol Rep 4 (2002) 359-367
56. Wandstrat A., and Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat Immunol 2 (2001) 802-809